Безопасен ли tallowamidopropyl hydroxysultaine при беременности?

Related ingredients

Frequently asked questions

Безопасен ли tallowamidopropyl hydroxysultaine при беременности?

No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR reproductive warnings found for tallowamidopropyl hydroxysultaine; peer‑reviewed reproductive toxicity data are not available. As an amphoteric surfactant with low expected systemic absorption from topical use, hazard and mechanism flags are not supported by authoritative sources, but low measurable dermal absorption is plausible for topical cosmetic use (PubChem/CosIng listings indicate typical surfactant use and low systemic toxicity).

Безопасен ли tallowamidopropyl hydroxysultaine при грудном вскармливании?

No evidence of reproductive or lactation-specific toxicity or harmonised classifications. Dermal exposure during breastfeeding would be expected to give low but measurable systemic availability at most, similar to pregnancy assessment; no data indicate transfer into breast milk.

Безопасен ли tallowamidopropyl hydroxysultaine для кожи малыша?

No infant-specific reproductive or developmental toxicity data found. Because infant skin (0–3 yr) has higher surface-area-to-weight and immature barrier, exposure score is increased by +1 versus adults (adult e=1 → baby e=2). No evidence supports increasing hazard or mechanism scores for infants.

Как VeriMom оценивает tallowamidopropyl hydroxysultaine?

VeriMom оценивает tallowamidopropyl hydroxysultaine в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы tallowamidopropyl hydroxysultaine при беременности?

См. наш список безопасных альтернатив tallowamidopropyl hydroxysultaine с аналогичной функцией и классификацией без известных рисков.